Across biology labs, the idea that aging might be governed by a few crucial switches is moving from science fiction to bench science. Instead of treating growing old as a slow, inevitable decline, ...

The connection arrived as Indianapolis hovered close. Momentum felt fragile. Purdy trusted the window anyway. Kittle secured the catch and the moment. The crowd responded. San Francisco exhaled. That ...

Investor confidence in traditional pharmaceutical models is declining, with enterprise-value-to-EBITDA multiples dropping from 13.6x to 11.5x between 2018 and 2024. Operational failures, such as ...